Yang YH, Speed T. Design issues for cDNA microarray experiments. Nat Rev Genet 2002; 3: 579–88.
Jovanovic BD, Bergan RC, Kibbe WA. Some aspects of analysis of gene array data. Cancer Treat Res 2002; 113: 71–89.
Carmeliet P, Ferreira V, Breier G et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435–9.
Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439–42.
Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2002; 2: 795–803.
Willett CG, Boucher Y, Di Tomaso E et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 2004; 10: 145–7.
Symes JF, Losordo DW, Vale PR et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 1999; 68: 830–6; discussion 836–7.
Simovic D, Isner JM, Ropper AH et al. Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia. Arch Neurol 2001; 58: 761–8.
Carmeliet P, Moons L, Luttun A et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7: 575–83.
Autiero M, Waltenberger J, Communi D et al. Role of PlGF in the intra-and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 2003; 9: 936–43.
Bussolati B, Dunk C, Grohman M et al. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 2001; 159: 993–1008.
Abe M, Sato Y. cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis 2001; 4: 289–98.
Vasile E, Tomita Y, Brown LF et al. Differential expression of thymosin ta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: Evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J 2001; 15: 458–66.
Jih YJ, Lien WH, Tsai WC et al. Distinct regulation of genes by bFGF and VEGF-A in endothelial cells. Angiogenesis 2001; 4: 313–21.
Weston GC, Haviv I, Rogers PA. Microarray analysis of VEGFresponsive genes in myometrial endothelial cells. Mol Hum Reprod 2002; 8: 855–63.
Yang S, Toy K, Ingle G et al. Vascular endothelial growth factorinduced genes in human umbilical vein endothelial cells: relative roles of KDR and Flt-1 receptors. Arterioscler Thromb Vasc Biol 2002; 22: 1797–803.
Zhang H-T, Gorn M, Smith KA et al. Transcriptional profiling of human microvascular endothelial cells in the proliferating and quiescent state using cDNA arrays. Angiogenesis 1999; 3: 211–9.
Liu D, Jia H, Holmes DI et al. Vascular endothelial growth factorregulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler Thromb Vasc Biol 2003; 23: 2002–7.
Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745–56.
Evans AL, Sharkey AS, Saidi S et al. Generation and use of a tailored gene array to investigate vascular biology. Angiogenesis 2003; 6: 93–104.
Long AD, Mangalam HJ, Chan BY et al. Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework. Analysis of global gene expression in Escherichia coli K12. J Biol Chem 2001; 276: 19937–44.
Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116–21.
Saidi SA, Holland CM, Kreil DP et al. Independent Component Analysis is a valid model for microarray analysis in endometrial cancer. Oncogene 2004; in press.
Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science 1995; 270: 484–7.
Johnson N, Sengupta S, Lessan K et al. Endothelial Cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation. FASEB J. 2003; 18: 188–190.
Ho M, Yang E, Matcuk G et al. Identification of endothelial cell genes by combined database mining and microarray analysis. Physiol Genomics 2003; 13: 249–62.
Clauss M, Gerlach M, Gerlach H et al. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990; 172: 1535–45.
Lu M, Perez VL, Ma N et al. VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci 1999; 40: 1808–12.
Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991; 181: 902–6.
Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 1992; 153: 557–62.
Gerber HP, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998; 273: 13313–6.
Marumo T, Schini-Kerth VB, Busse R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 1999; 48: 1131–7.
Kim I, Moon SO, Kim SH, et al. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factorkappa B activation in endothelial cells. J Biol Chem 2001; 276: 7614–20.